| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |